HLA Class II-DRB1 Alleles with Hepatitis C Virus Infection Outcome in Egypt: A Multicentre Family-based Study.

INTRODUCTION AND AIM

Hepatitis C virus (HCV) infection is a global medical problem. HLA -DRB1 alleles have an important role in immune response against HCV. The aim of this study is to clarify the contribution of HLA -DRB1 alleles in HCV susceptibility in a multicentre family-based study.

MATERIAL AND METHODS

A total of 162 Egyptian families were recruited in this study with a total of 951 individuals (255 with chronic hepatitis C (CHC), 588 persons in the control group(-ve household contact to HCV) and 108 persons who spontaneously cleared the virus (SVC). All subjects were genotyped for HLA -DRB1 alleles by SSP-PCR and sequence based typing (SBT) methods.

RESULTS

The carriage of alleles 3:01:01 and 13:01:01 were highly significant in CHC when compared to that of control and SVC groups [OR of 3 family = 5.1289, P (Bonferroni correction ) = 0.0002 and 5.9847, P = 0.0001 and OR of 13 family = 4.6860, P = 0.0002 and OR = 6.5987, P = 0.0001 respectively]. While DRB1040501, DRB1040101, DRB17:01:01 and DRB1110101 alleles were more frequent in SVC group than CHC patients (OR = 0.4052, P = 0.03, OR: OR = 0.0916,P = 0.0006, OR = 0.1833,P = 0.0006 and OR = 0.4061, P = 0.0001 respectively).

CONCLUSIONS

It was concluded that among the Egyptian families, HLA-DRB1030101, and DRB1130101 alleles associated with the risk of progression to CHC infection, while DRB1040101, DRB1040501, DRB17:01:01and DRB1110101 act as protective alleles against HCV infection.